The issue of financial toxicity in the management of chronic myeloid leukemia with blast crisis

JOURNAL ARTICLE published 3 July 2018 in Journal of Medical Economics

Authors: Ahmet Emre Eskazan

A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer

JOURNAL ARTICLE published January 2008 in Journal of Medical Economics

Authors: Livio Garattini | Paola De Compadri | Daniela Koleva | Luca Pasina | Alessandro Nobili

Exploratory analysis of psychiatric-related utilization and costs associated with paliperidone ER compared with other oral atypical antipsychotics using pharmacy claims from an administrative database

JOURNAL ARTICLE published December 2010 in Journal of Medical Economics

Authors: J.M. Panish | R. Dirani | R. Halpern | F. Cao

Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis

JOURNAL ARTICLE published 3 April 2017 in Journal of Medical Economics

Authors: Guangying Sheng | Suning Chen | Chaohui Dong | Ri Zhang | Miao Miao | Depei Wu | Seng Chuen Tan | Chao Liu | Tengbin Xiong

Economic evaluation of MF59 adjuvanted vaccine against influenza in the high-risk elderly population in France

JOURNAL ARTICLE published January 2004 in Journal of Medical Economics

Authors: James Piercy | James Ryan | Francoise Megas

Contingent valuation of inhaled insulin: a Canadian perspective

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Hamid Sadri

Retrospective study comparing healthcare costs and utilization between commercially insured patients with type 2 diabetes mellitus who are newly initiating exenatide once weekly or liraglutide in the United States

JOURNAL ARTICLE published 2 September 2015 in Journal of Medical Economics

Authors: Stephen S. Johnston | Hiep Nguyen | Katherine Cappell | James K. Nelson | Bong-Chul Chu | Iftekhar Kalsekar

The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular risk

JOURNAL ARTICLE published 3 July 2015 in Journal of Medical Economics

Authors: M. S. Penn | M. A. Yenikomshian | A. K. G. Cummings | A. Klemes | J. M. Damron | S. Purvis | M. Beidelschies | H. G. Birnbaum

Impact of formulary management and step therapy for non-sedating antihistamines on prescription drug utilisation and costs

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Shawn X Sun | Yonghua Jing | Kwan Y Lee | Jennifer McMurray | Elizabeth Young

Specialty pharmaceuticals and the quest for better outcomes

JOURNAL ARTICLE published 2 January 2016 in Journal of Medical Economics

Authors: Richard A. Brook

Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy

JOURNAL ARTICLE published August 2013 in Journal of Medical Economics

Authors: Vamsi Bollu | Flavia Ejzykowicz | Krithika Rajagopalan | John Karafilidis | Joel W. Hay

Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures

JOURNAL ARTICLE published 3 June 2017 in Journal of Medical Economics

Authors: D. Makhija | M. Rock | Y. Xiong | J. D. Epstein | M. R. Arnold | O. M. Lattouf | D. Calcaterra

Costing bias in economic evaluations

JOURNAL ARTICLE published 3 August 2015 in Journal of Medical Economics

Authors: Julie Frappier | Gabriel Tremblay | Mark Charny | L. Martin Cloutier

The association between smoking cessation outpatient visits and total medical costs: a retrospective, observational analysis of Japanese employee-based public health insurance data

JOURNAL ARTICLE published 4 May 2018 in Journal of Medical Economics

Authors: Kiyomi Suwa | Reiko Yoshikawa | Kosuke Iwasaki | Ataru Igarashi

A discrete choice experiment investigating HIV testing preferences in South Africa

JOURNAL ARTICLE published 31 December 2022 in Journal of Medical Economics

Authors: P. Chiwire | A. C. Mühlbacher | S. M. Evers | H. Mahomed | J. Ostermann | M. Hiligsmann

Cost and effectiveness of brinzolamide versus dorzolamide in current practice: an analysis based on the UK-GPRD database

JOURNAL ARTICLE published January 2003 in Journal of Medical Economics

Authors: Céline Deschaseaux-Voinet | Antoine Lafuma | Gilles Berdeaux

Essential need for research in hepatitis C

JOURNAL ARTICLE published 3 July 2015 in Journal of Medical Economics

Authors: J. S. McCombs

Preeclampsia in Switzerland: a cost analysis in two hospitals

JOURNAL ARTICLE published 1 September 2020 in Journal of Medical Economics

Authors: Markus Hodel | Patricia R. Blank | Petra Marty | Olav Lapaire

Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin

JOURNAL ARTICLE published 2 January 2016 in Journal of Medical Economics

Authors: Geno J. Merli | Judd E. Hollander | Patrick Lefebvre | François Laliberté | Monika K. Raut | Guillaume Germain | Brahim Bookhart | Charles V. Pollack

Correction

JOURNAL ARTICLE published 31 December 2024 in Journal of Medical Economics